Perrigo Company plc (PRGO)
NYSE: PRGO · Real-Time Price · USD
21.60
-0.34 (-1.55%)
At close: Oct 28, 2025, 4:00 PM EDT
21.60
0.00 (0.00%)
Pre-market: Oct 29, 2025, 8:02 AM EDT
Perrigo Company Revenue
Perrigo Company had revenue of $1.06B in the quarter ending June 28, 2025, a decrease of -0.86%. This brings the company's revenue in the last twelve months to $4.33B, down -2.31% year-over-year. In the year 2024, Perrigo Company had annual revenue of $4.37B, down -6.06%.
Revenue (ttm)
$4.33B
Revenue Growth
-2.31%
P/S Ratio
0.69
Revenue / Employee
$516,303
Employees
8,379
Market Cap
2.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.37B | -282.20M | -6.06% |
| Dec 31, 2023 | 4.66B | 204.00M | 4.58% |
| Dec 31, 2022 | 4.45B | 312.90M | 7.56% |
| Dec 31, 2021 | 4.14B | 50.50M | 1.24% |
| Dec 31, 2020 | 4.09B | 218.30M | 5.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
PRGO News
- 1 day ago - 49 October Hi-Yield S&P Aristocrats: 5 To Buy - Seeking Alpha
- 7 days ago - Perrigo to Release Third Quarter 2025 Financial Results on November 5, 2025 - PRNewsWire
- 13 days ago - Perrigo: Business And Share Price Could Be Finally Bottoming Out - Seeking Alpha
- 14 days ago - Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks With Over 3% Dividend Yields - Benzinga
- 20 days ago - Opill® Nails It with First-Ever Brand Collaboration, Launching 'Opill and Chill' With Chillhouse - PRNewsWire
- 4 weeks ago - 51 September S&P Hi-Yield Aristocrats: 5 To Buy - Seeking Alpha
- 2 months ago - Perrigo to Attend Barclays 18th Annual Global Consumer Staples Conference - PRNewsWire
- 2 months ago - Perrigo Company plc (PRGO) Q2 2025 Earnings Call Transcript - Seeking Alpha